Mary Chapman is an award-winning journalist who writes feature stories for Huntington's Disease News. She covers the latest news and information on a variety of Huntington's disease topics.| Huntington's Disease News
Ingrezza is an oral medication approved in the U.S. for chorea, or the involuntary, jerky movements that characterize Huntington’s disease.| Huntington's Disease News
Learn more about chorea, the most common involuntary movement problem in Huntington’s disease patients. Chorea usually occurs several years after disease onset.| Huntington's Disease News
Category archive page for News.| Huntington's Disease News
Huntington's disease is a neurodegenerative disorder that can cause movement, thinking and psychiatric problems.| Huntington's Disease News
